224 related articles for article (PubMed ID: 15221335)
21. RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease.
Donahue JE; Flaherty SL; Johanson CE; Duncan JA; Silverberg GD; Miller MC; Tavares R; Yang W; Wu Q; Sabo E; Hovanesian V; Stopa EG
Acta Neuropathol; 2006 Oct; 112(4):405-15. PubMed ID: 16865397
[TBL] [Abstract][Full Text] [Related]
22. Differential expression of phosphorylated translation initiation factor 2 alpha in Alzheimer's disease and Creutzfeldt-Jakob's disease.
Ferrer I
Neuropathol Appl Neurobiol; 2002 Dec; 28(6):441-51. PubMed ID: 12445160
[TBL] [Abstract][Full Text] [Related]
23. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA
J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525
[TBL] [Abstract][Full Text] [Related]
24. Acetyl-L-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease.
Abdul HM; Calabrese V; Calvani M; Butterfield DA
J Neurosci Res; 2006 Aug; 84(2):398-408. PubMed ID: 16634066
[TBL] [Abstract][Full Text] [Related]
25. Oxidative stress damage and oxidative stress responses in the choroid plexus in Alzheimer's disease.
Perez-Gracia E; Blanco R; Carmona M; Carro E; Ferrer I
Acta Neuropathol; 2009 Oct; 118(4):497-504. PubMed ID: 19597827
[TBL] [Abstract][Full Text] [Related]
26. CD36 overexpression in human brain correlates with beta-amyloid deposition but not with Alzheimer's disease.
Ricciarelli R; D'Abramo C; Zingg JM; Giliberto L; Markesbery W; Azzi A; Marinari UM; Pronzato MA; Tabaton M
Free Radic Biol Med; 2004 Apr; 36(8):1018-24. PubMed ID: 15059642
[TBL] [Abstract][Full Text] [Related]
27. Regression stage senile plaques in the natural course of Alzheimer's disease.
Oide T; Kinoshita T; Arima K
Neuropathol Appl Neurobiol; 2006 Oct; 32(5):539-56. PubMed ID: 16972888
[TBL] [Abstract][Full Text] [Related]
28. Resistance of the hippocampus in Creutzfeldt-Jakob disease.
Masullo C; Macchi G
Clin Neuropathol; 1997; 16(1):37-44. PubMed ID: 9020394
[TBL] [Abstract][Full Text] [Related]
29. Progranulin expression correlates with dense-core amyloid plaque burden in Alzheimer disease mouse models.
Pereson S; Wils H; Kleinberger G; McGowan E; Vandewoestyne M; Van Broeck B; Joris G; Cuijt I; Deforce D; Hutton M; Van Broeckhoven C; Kumar-Singh S
J Pathol; 2009 Oct; 219(2):173-81. PubMed ID: 19557827
[TBL] [Abstract][Full Text] [Related]
30. GluR2/3, NMDAepsilon1 and GABAA receptors in Creutzfeldt-Jakob disease.
Ferrer I; Puig B
Acta Neuropathol; 2003 Oct; 106(4):311-8. PubMed ID: 12835949
[TBL] [Abstract][Full Text] [Related]
31. Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer's disease.
Aucoin JS; Jiang P; Aznavour N; Tong XK; Buttini M; Descarries L; Hamel E
Neuroscience; 2005; 132(1):73-86. PubMed ID: 15780468
[TBL] [Abstract][Full Text] [Related]
32. Ferulic acid ethyl ester protects neurons against amyloid beta- peptide(1-42)-induced oxidative stress and neurotoxicity: relationship to antioxidant activity.
Sultana R; Ravagna A; Mohmmad-Abdul H; Calabrese V; Butterfield DA
J Neurochem; 2005 Feb; 92(4):749-58. PubMed ID: 15686476
[TBL] [Abstract][Full Text] [Related]
33. Cerebrovascular P-glycoprotein expression is decreased in Creutzfeldt-Jakob disease.
Vogelgesang S; Glatzel M; Walker LC; Kroemer HK; Aguzzi A; Warzok RW
Acta Neuropathol; 2006 May; 111(5):436-43. PubMed ID: 16523342
[TBL] [Abstract][Full Text] [Related]
34. Oxidative stress induces intralysosomal accumulation of Alzheimer amyloid beta-protein in cultured neuroblastoma cells.
Zheng L; Roberg K; Jerhammar F; Marcusson J; Terman A
Ann N Y Acad Sci; 2006 May; 1067():248-51. PubMed ID: 16803994
[TBL] [Abstract][Full Text] [Related]
35. Apolipoprotein D is a component of compact but not diffuse amyloid-beta plaques in Alzheimer's disease temporal cortex.
Desai PP; Ikonomovic MD; Abrahamson EE; Hamilton RL; Isanski BA; Hope CE; Klunk WE; DeKosky ST; Kamboh MI
Neurobiol Dis; 2005 Nov; 20(2):574-82. PubMed ID: 15916898
[TBL] [Abstract][Full Text] [Related]
36. Clusterin solubility and aggregation in Creutzfeldt-Jakob disease.
Freixes M; Puig B; Rodríguez A; Torrejón-Escribano B; Blanco R; Ferrer I
Acta Neuropathol; 2004 Oct; 108(4):295-301. PubMed ID: 15235804
[TBL] [Abstract][Full Text] [Related]
37. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
van de Nes JA; Nafe R; Schlote W
Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
[TBL] [Abstract][Full Text] [Related]
38. Increased density of metallothionein I/II-immunopositive cortical glial cells in the early stages of Alzheimer's disease.
Adlard PA; West AK; Vickers JC
Neurobiol Dis; 1998 Nov; 5(5):349-56. PubMed ID: 10069577
[TBL] [Abstract][Full Text] [Related]
39. Is brain copper deficiency in Alzheimer's, Lewy body, and Creutzfeldt Jakob diseases the common key for a free radical mechanism and oxidative stress-induced damage?
Deloncle R; Guillard O
J Alzheimers Dis; 2015; 43(4):1149-56. PubMed ID: 25125459
[TBL] [Abstract][Full Text] [Related]
40. The spatial patterns of prion protein deposits in Creutzfeldt-Jakob disease: comparison with beta-amyloid deposits in Alzheimer's disease.
Armstrong RA; Lantos PL; Cairns NJ
Neurosci Lett; 2001 Jan; 298(1):53-6. PubMed ID: 11154834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
